Publicaciones en colaboración con investigadores/as de Institute of Oncology Ljubljana (21)

2024

  1. Radiotherapy with 15 × 2.633 Gy vs. 20 × 2.0 Gy in Patients with Malignant Spinal Cord Compression and Favorable Survival Prognoses: A Secondary Analysis of the RAMSES-01 Trial

    Cancers, Vol. 16, Núm. 20

2023

  1. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes

    The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106

2022

  1. A New and Easy-to-Use Survival Score for Patients Irradiated for Metastatic Epidural Spinal Cord Compression

    Practical Radiation Oncology, Vol. 12, Núm. 4, pp. 354-362

  2. Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy

    Radiation Oncology, Vol. 17, Núm. 1

2021

  1. Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials

    Radiation Oncology, Vol. 16, Núm. 1

2020

  1. Precision Radiation Therapy for Metastatic Spinal Cord Compression: Final Results of the PRE-MODE Trial

    International Journal of Radiation Oncology Biology Physics, Vol. 106, Núm. 4, pp. 780-789

2019

  1. Patient-Reported Outcomes–Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy × 5 to 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression

    International Journal of Radiation Oncology Biology Physics, Vol. 105, Núm. 4, pp. 760-764

  2. Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): A prospective multicenter study

    BMC Cancer, Vol. 19, Núm. 1

2018

  1. 1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: A matched-pair study of three prognostic patient subgroups

    Radiation Oncology, Vol. 13, Núm. 1

  2. A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression

    Radiation Oncology, Vol. 13, Núm. 1

  3. Comparison of two radiotherapy regimens for metastatic spinal cord compression: Subgroup analyses from a randomized trial

    Anticancer Research, Vol. 38, Núm. 2, pp. 1009-1015

2017

  1. High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): A multicenter phase 2 study

    BMC Cancer, Vol. 17, Núm. 1

  2. Results of a multicenter study investigating the potential impact of the overall treatment time on outcomes of radiation therapy alone with 5×4 Gy for metastatic epidural spinal cord compression

    Practical Radiation Oncology, Vol. 7, Núm. 2, pp. 137-144

  3. Role of the overall treatment time of radiotherapy with 10 × 3 Gy for outcomes in patients with metastatic spinal cord compression

    Journal of Medical Imaging and Radiation Oncology, Vol. 61, Núm. 3, pp. 388-393

2016

  1. A prognostic instrument to estimate the survival of elderly patients irradiated for metastatic epidural spinal cord compression from lung cancer

    Clinical Lung Cancer, Vol. 17, Núm. 4, pp. 279-284

  2. Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myeloma

    Radiology and Oncology, Vol. 50, Núm. 3, pp. 337-340

  3. Radiation therapy alone provides excellent outcomes for spinal cord compression from vertebral lymphoma

    Anticancer Research, Vol. 36, Núm. 6, pp. 3081-3083

  4. Radiotherapy with 4 Gy × 5 versus 3 Gy × 10 for metastatic epidural spinal cord compression: Final results of the SCORE-2 Trial (ARO 2009/01)

    Journal of Clinical Oncology, Vol. 34, Núm. 6, pp. 597-602

2015

  1. A new instrument for estimation of survival in elderly patients irradiated for metastatic spinal cord compression from breast cancer

    Radiation Oncology, Vol. 10, Núm. 1

  2. Metastatic spinal cord compression: A survival score particularly developed for elderly prostate cancer patients

    Anticancer Research, Vol. 35, Núm. 11, pp. 6189-6192